A small molecule induces integrin β4 nuclear translocation and apoptosis selectively in cancer cells with high
Shu Yan Liu1, Di Ge2,3, Li Na Chen1
1Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Science, Shandong University, Jinan 250100, China.
Abstract:
Increased integrin β4 (ITGB4) level is accompanied by malignant progression of multiple carcinomas. However, selective therapeutic strategies against cancer cells expressing a high level of ITGB4 have not been reported. Here, for the first time, we report that a chiral small molecule, SEC, selectively promotes apoptosis in cancer cells expressing a high level of ITGB4 by inducing ITGB4 nuclear translocation. Nuclear ITGB4 can bind to the ATF3 promoter region and activate the expression of ATF3, then upregulate the downstream pro-apoptosis genes. Furthermore, SEC promoted the binding of annexin A7 (ANXA7) to ITGB4 and increased ANXA7 GTPase activity. Activated ANXA7 promoted ITGB4 nuclear translocation by triggering ITGB4 phosphorylation at Y1494. SEC also inhibited the growth of xenograft tumors in the avian embryo model. We identified a small molecule, SEC, with selective pro-apoptosis effects on cancer cells with high expression of ITGB4, both in vitro and in vivo, by triggering the binding of ITGB4 and ANXA7, ITGB4 nuclear trafficking, and pro-apoptosis gene expression.
Insights
A novel small molecule, SEC, selectively induces cancer cell death in tumors with high integrin β4 (ITGB4) expression. This targeted approach involves ITGB4 nuclear translocation, activating pro-apoptosis genes for potential new cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Elevated integrin β4 (ITGB4) expression correlates with advanced carcinoma progression.
- Targeted therapies for ITGB4-high cancer cells remain underdeveloped.
Purpose of the Study:
- To identify and characterize a small molecule that selectively targets cancer cells with high ITGB4 expression.
- To elucidate the molecular mechanisms underlying the selective anti-cancer effects of the identified molecule.
Main Methods:
- Screening of small molecules for selective cytotoxicity against ITGB4-expressing cancer cells.
- Investigating the role of ITGB4 nuclear translocation and its downstream effects.
- Assessing the efficacy of the small molecule in an avian embryo xenograft tumor model.
Main Results:
- A chiral small molecule, SEC, was identified that selectively induces apoptosis in cancer cells with high ITGB4 levels.
- SEC promotes ITGB4 nuclear translocation, leading to ATF3 activation and upregulation of pro-apoptotic genes.
- SEC enhances annexin A7 (ANXA7) binding to ITGB4, increasing ANXA7 GTPase activity and ITGB4 phosphorylation at Y1494.
- SEC demonstrated significant inhibition of xenograft tumor growth in vivo.
Conclusions:
- SEC represents a novel therapeutic agent with selective pro-apoptotic activity against ITGB4-high cancers.
- The mechanism involves SEC-mediated ITGB4-ANXA7 interaction, nuclear trafficking, and subsequent activation of apoptotic pathways.
- SEC shows promise for both in vitro and in vivo cancer treatment strategies targeting ITGB4 expression.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
The Intrinsic Apoptotic Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
The Extrinsic Apoptotic Pathway
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
